Artificial Intelligence
12.3% CAGR, Circulating Tumor Cells Market to Reflect US$ 9.85 Billion by 2030: Reports Insights
<!– Name:DistributionId Value:8777173 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1265965 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:56011922-eb03-4830-865d-5b33bbc27cb3 –>
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) — The Circulating Tumor Cells (CTC) Market is projected to grow at a CAGR of 12.3% from 2023 to 2030, with a value of USD 9.85 Billion by 2030, according to the research report by Reports Insights. The market was valued at USD 3.89 Billion in 2022. The report analyzes the market by segmenting it into different components such as product type, technology, application, end-user, and region. It provides a detailed analysis of the competitive landscape of the market, including key players, their strategies, and market share.
The inclusive market research report on the circulating tumor cells market is offered by Reports Insights Pvt. Ltd. The research provides an in-depth analysis of macroeconomic statistics such as market dynamics, segmental analysis, SWOT analysis, and others. Several trends and opportunities in major segments such as technology, specimen, product, application, end-user, and region are revealed by the study. The report also focuses on major insights which prove significance to key companies in terms of innovative approaches to strengthen their market position.
Get Sample Report@ https://www.reportsinsights.com/sample/673786
With increased global incidences of cancer, the demand for circulating tumor cells (CTC)-based diagnostics and therapeutics is also estimated to witness a significant increase among diagnostic centers and academic and research institutes.
The development of high-throughput screening and imaging technologies is expected to enable large-scale usage of CTCs detection and analysis with greater sensitivity and specificity in terms of advancements in technology.
Growing demand for customized or tailored medicine is anticipated to boost the sales of CTCs for the identification of tumor-specific biomarkers and the monitoring of treatment response.
Rising awareness about the ability of CTCs to detect cancer at an early stage, even before the onset of symptoms is expected to support the market expansion during the forecast period.
The integration of artificial intelligence (AI) in CTC-based diagnostics is anticipated to offer opportunities for the market players in the healthcare industry. The high demand for AI to improve the accuracy and efficiency of CTC-based diagnostics resulted in offering accurate and personalized cancer treatment.
Circulating Tumor Cells Market Report Coverage:-
| Report Attributes | Report Details |
| Market Size By 2030 | USD 9.85 Billion |
| Forecast Period | 2023-2030 |
| CAGR (2023-2030) | 12.3% |
| Base Year | 2022 |
| Study Timeline | 2017-2030 |
| Key Players | Fluxion Biosciences Inc., Bio-Techne, Precision Medicine Group, LLC., QIAGEN, Aviva Systems Biology Corporation, BIOCEPT, Inc., Thermo Fisher Scientific, Greiner Bio One International GmbH, Ikonisys Inc., Miltenyi Biotec, IVDiagnostics, BioFluidica, Canopus Bioscience Ltd., Biolidics Limited, Creativ MicroTech, Inc., LungLife AI, Inc., Epic Sciences, Rarecells Diagnostics, ScreenCell, Menarini Silicon Biosystems, LineaRx, Inc. (Vitatex, Inc.), Sysmex Corporation, STEMCELL Technologies, Inc. |
| By Technology | CTC Detection And Enrichment Methods (Immunocapture (Label-Based) (Negative Enrichment, Positive Enrichment), Size-Based Separation (Label-Free) (Membrane-Based, Microfluidic-Based), Density-Based Separation (Label-Free), Combined Methods (Label-Free), Others) CTC Detection Methods (SERS, Microscopy, Others), CTC Analysis |
| By Specimen | Blood, Bone Marrow, and Other Body Fluids |
| By Product | Kits & Reagents, Blood Collection Tubes, Devices, or Systems |
| By Application | Clinical/ Liquid Biopsy (Risk Assessment, Screening, and Monitoring), Research (Cancer Stem Cell & Tumorogenesis Research, Drug/Therapy Development) |
| By End Use | Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutes, Others |
| Report Coverage | Company Ranking and Market Share, Growth Factors, Total Revenue Forecast, Regional Competitive Landscape, Business Strategies, and more. |
| By Geography | North America [United States, Canada, Mexico]
Asia-Pacific [China, Southeast Asia, Japan, India, Korea, Western Asia] South America [Brazil, Argentina, Columbia, Chile, Peru] Europe [Germany, UK, Spain, Turkey, France, Italy, Russia, Netherlands, Switzerland] Middle East & Africa [GCC, North Africa, South Africa] |
Immediate Delivery Available, Buy Now @ https://www.reportsinsights.com/buynow/673786
The development of CTC-based liquid biopsy assays is expected to offer opportunities for sustainable growth for the market of circulating tumor cells as liquid biopsy is a non-invasive method of cancer diagnosis and treatment monitoring. Such a method uses biofluids, specifically blood, to detect and analyze cancer biomarkers is anticipated to further boost the demand for CTCs that allow for early cancer detection, personalized treatment, and monitoring of treatment response.
The expansion of CTC-based diagnostics in oncology, including prognostic, predictive, and companion diagnostics is estimated to push forward the market growth during the forecast period. The high demand for CTC-based diagnostics to provide valuable information about cancer biology, treatment response, and disease progression is projected to accelerate market growth.
Collaboration and partnerships by major market players will lead to the development of new CTC-based technologies and therapies, as well as the validation of existing ones by innovations and technological advancements.
In terms of technology, CTC detection and enrichment methods are expected to witness a sudden increase in demand during the forecast period. By analyzing the genetic and molecular characteristics of CTCs, researchers can identify potential targets for new cancer treatments and develop more personalized approaches to cancer therapy with the help of such detection methods.
CTC detection and enrichment methods find major application in the post-treatment of minimal residual disease (MRD) and identification of specific biomarkers or genetic mutations in cancer cells. The main reason for such applications is due to the usage of CTC detection and enrichment methods in cancer research and clinical practice to identify and isolate cancer cells that have detached from the primary tumor and entered the bloodstream.
Key Market Takeaways
- The global circulating tumor cells market size is expected to garner USD 9.85 billion by 2030 and expand at a CAGR of 12.3% during the forecast period (2023-2030).
- Based on technology, the CTC detection and enrichment methods segment contributed the largest market share over 69.7% in 2022.
- By specimen, the blood segment is anticipated to contribute the largest shares of the global circulating tumor cells market by 2030.
- In the context of product, the devices or systems segment is projected to dominate the market statistics during the forecast period.
- Based on application, the research segment is expected to lead the market growth with over 75.6% of the overall market shares.
- By end use, diagnostic centers are expected to support the increased circulating tumor cells market statistics by 2030.
- North America is projected to lead the market growth with excellent revenue shares due to access to astonishing healthcare infrastructure, including treatment facilities and advanced diagnostics.
- With rising expenditures on research and development of new medical technologies by the government, Asia Pacific is also estimated to contribute substantial shares to the market growth over the forecasted period.
Circulating Tumor Cells Market Growth Drivers:
- Increased investments by government and private organizations globally in research and development of CTC-based diagnostics and therapeutics result in the sustainable growth of the market for circulating tumor cells.
- The development of new single-cell analysis technologies such as single-cell RNA sequencing boosts market statistics as the analysis allows for the identification of tumor-specific biomarkers, the monitoring of treatment response, and the development of new cancer therapies.
- Growing usage of CTC-based assays in clinical trials drives the sales of such CTC to evaluate the efficacy of new cancer therapies.
Restraints
- The risks of ethical concerns in terms of patient privacy and informed consent mainly limit the adoption of CTCs for diagnostics and treatments in case of their acceptance and usage in several settings.
- The presence of alternative technologies such as liquid biopsy and next-generation sequencing that offer similar benefits as CTC-based diagnostics restricts the market share of CTC-based products.
Competitive Landscape
According to the Reports Insights, Menarini Silicon Biosystems, Epic Sciences, QIAGEN, Cynvenio Biosystems, and Biocept are expected to be leading market players along with other companies such as Fluxion Biosciences Inc., Miltenyi Biotec, ScreenCell, and Rarecells. The landscape of the circulating tumor cells market is constantly evolving as new companies enter the space and existing players expand their product offerings. There are also a number of academic and research institutions that are working on developing new technologies for the detection and analysis of CTCs, which is expected to potentially disrupt the existing market. Overall, the CTC market is highly competitive and is estimated to continue to grow as liquid biopsy of CTC becomes an increasingly important tool for cancer diagnosis and treatment.
Browse Full Report @ https://www.reportsinsights.com/industry-forecast/global-circulating-tumor-cells-market-statistical-analysis-673786
Recent Developments
- In October 2020, LungLife AI, a leading liquid biopsy technology company for cancer diagnosis and management, announced that they expect to publish clinical data related to a research collaboration on the early detection of lung cancer at the International Association for the Study of Lung Cancer (IASLC) Hot Topic Meeting.
- In February 2021, Bio-Techne Corporation stated that their Exosome Diagnostics brand published a research paper titled “Exosome-based Liquid Biopsies in Cancer: Opportunities and Challenges” in the high-rated peer-reviewed journal Annals of Oncology. The paper provides unique insights into liquid biopsies, including CTC analysis and cfDNA, for cancer diagnosis.
- In December 2021, Rarecells, Inc., a well-known liquid biopsy company specializing in non-invasive tests for early cancer diagnosis, declared that the business secured USD 5 million in funding, bringing the total Series A funding to USD 13 million. The funds will be used to support the launch of clinical operations and a laboratory in the United States which is focused on early detection tests for prostate cancer and acute myeloid leukemia.
List of Major Circulating Tumor Cells Market Players
• Fluxion Biosciences Inc.
• Bio-Techne
• Precision Medicine Group, LLC.
• QIAGEN
• Aviva Systems Biology Corporation
• BIOCEPT, Inc.
• Thermo Fisher Scientific
• Greiner Bio One International GmbH
• Ikonisys Inc.
• Miltenyi Biotec
• IVDiagnostics
• BioFluidica
• Canopus Bioscience Ltd.
• Biolidics Limited
• Creativ MicroTech, Inc.
• LungLife AI, Inc.
• Epic Sciences
• Rarecells Diagnostics
• ScreenCell
• Menarini Silicon Biosystems
• LineaRx, Inc. (Vitatex, Inc.)
• Sysmex Corporation
• STEMCELL Technologies, Inc.
• Cynvenio Biosystems
Global Circulating Tumor Cells Market Segmentation:
- By Technology
- CTC Detection And Enrichment Methods
- Immunocapture (Label-Based)
- Negative Enrichment
- Positive Enrichment
- Size-Based Separation (Label-Free)
- Membrane-Based
- Microfluidic-Based
- Density-Based Separation (Label-Free)
- Combined Methods (Label-Free)
- Others
- Immunocapture (Label-Based)
- CTC Detection Methods
- SERS
- Microscopy
- Others
- CTC Analysis
- CTC Detection And Enrichment Methods
- By Specimen
- Blood
- Bone Marrow
- Other Body Fluids
- By Product
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
- By Application
- Clinical/ Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell & Tumorogenesis Research
- Drug/Therapy Development
- Clinical/ Liquid Biopsy
- By End Use
- Hospital and Clinics
- Diagnostic Centers
- Research and Academic Institutes
- Others
Key Questions Covered in the Circulating Tumor Cells Market Report
What are the factors that drive the growth of market circumstances during the forecast period?
Which region is expected to account for the largest share contribution to the market statistics from 2023-2030?
What is the projected valuation of the circulating tumor cells market in 2030?
Which segment is expected to contribute the largest shares to the market growth from 2023-2030?
What are the market opportunities that will result in the sustainable growth of the circulating tumor cells industry over the forecasted period?
Our Others Research Reports here:-
Hospital Asset Management Market Size, Share & Trends Analysis, By Product Type (Radio-Frequency Identification (RFID) Systems, Real-Time Location Systems (RTLS), Ultrasound and Infrared Sensors, Barcode Scanners, and Others), Application (Inventory Management, Equipment Tracking, Patient Tracking, Staff Management, Instrument Management, Supply Chain Management, and Others), End-User (Hospitals, Laboratories, Clinics, Ambulatory Surgical Centers, Pharmaceutical Companies, Biotechnology Companies, and Others), By Region, Forecast Period 2023 – 2030
Virtual Reality (VR) in Healthcare Market Size, Share & Trends Analysis, By Component (Hardware, Software, and Service), Technology (Full-Immersive, Semi-Immersive, and Non-Immersive), Application (Training and Education, Surgery, Patient Care Management, Rehabilitation & Adjunctive Therapy, Pain Management & Physical Therapy, and Medical Device Marketing), End Use (Hospitals & Surgical Centers, Research Organizations & Pharma Companies, Government & Defense medical Institutions, Research & Diagnostics Laboratories, and Others), Region and Segment, Forecast Period-2023 – 2030.
Virtual Reality Market Size, Share & Trends Analysis, By Component (Hardware and Software), Device Type (Head Mounted Display (HMD), Gesture Tracking Device, Projectors & Display Walls, and 3D Cameras), End-Use (Consumer Electronics, Healthcare, Retail, Education, and Others), By Region, Forecast Period 2023 – 2030.
Biopharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis, By Source (Mammalian and Microbial (Non-Mammalian)), Product Type (Biologics (Monoclonal Antibodies (MAbs), Recombinant Proteins, Vaccines), Antisense, RNAi, & Molecular Therapy, Biosimilars), Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), Therapeutic Area (Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Oncology, Neurology, Infectious Diseases, Respiratory Diseases, Others) By Region and Segment, Forecast Period 2023 – 2030
Bioelectronics Market Size, Share & Trends Analysis, By Type (Bio-Electronic Devices, Bio-Electronic Medicine), Product Type (Electrochemical Biosensors, Piezoelectric Biosensors, Others), Application (Fabrication Templates, Artificial Organs, Others), End User, Region and Segment, Forecast Period-2022 – 2030.
Artificial Intelligence
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
SINGAPORE, April 20, 2024 /PRNewswire/ — Aurionpro Solutions Limited (BSE: 532668) (NSE: AURIONPRO) announces the acquisition of Banking and Insurance focused PaaS startup, Arya.ai. With Arya.ai, Aurionpro will enhance its portfolio of enterprise fintech offerings to expedite adoption of AI that is responsible, accurate, and auditable.
Aurionpro Solutions Ltd. will acquire a majority stake (67%) in Arya.ai. This acquisition will bring products and expertise in Artificial Intelligence, Deep Learning, Intelligent Automation, PaaS, Autonomous AI Platforms, and more, to complement and strengthen Aurionpro’s industry leading portfolio.
The transaction comprises acquisition of shares held by the existing shareholders and subscription of new equity capital in the company. This will be an all-cash deal. The aggregate investment including secondary acquisition and fund infusion is approximately 16.5 MN USD.
By integrating Arya.ai’s cutting-edge AI cloud platform, with Aurionpro’s comprehensive suite of offerings, the company will create an industry leading Enterprise AI platform focused on creating value for financial institutions globally.
Commenting on the acquisition, Ashish Rai, CEO of Aurionpro Solutions, stated, “The acquisition of Arya.ai marries Aurionpro’s portfolio of industry leading enterprise software with one of the most mature Enterprise AI platforms focused on Banks and Insurers. We are incredibly excited about working with Arya.ai and our wider ecosystem partners to build out the leading Enterprise AI platform, for the financial industry worldwide.”
“Our decade long experience in building tools/platform for deep learning helped us to build a truly verticalized AI Operating System for Banking and Insurance.” Says Vinay Kumar CEO/Founder of Arya.ai. “Together with Aurionpro, we are going to build a new generation of Enterprise AI software for Banks and Insurers that truly embeds AI, augmenting a task or Autonomous Agents that can take over entire transactions”.
Founded in 2013 by Vinay Kumar and Deekshith Marla, Arya.ai has been one of the first ‘AI’ startups to use Deep Learning and deploy in enterprises. Arya.ai’s BFSI PaaS offerings include Arya API with 80+ ML models, Libra for fine-tuning SOTA ML models, and AryaXAI for AI governance.
Photo – https://mma.prnewswire.com/media/2392705/Aurionpro_solutions.jpgLogo – https://mma.prnewswire.com/media/2392706/Aurionpro_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/aurionpro-solutions-acquires-aryaai-to-power-next-generation-enterprise-ai-platforms-for-financial-institutions-302122674.html
Artificial Intelligence
Free Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
NEW YORK, April 19, 2024 /PRNewswire/ — Outdoor smart AR glasses, QIDI Vida, will officially launch on 23rd April on the Kickstarter platform. QIDI Vida integrates the many functions of smart watches, sports headphones, cycling computers, heart rate monitors, and walkie-talkies using AR+AI technology, allowing users to bid farewell to cumbersome device management and enjoy outdoor sports anytime, anywhere with just one pair of glasses.
Function:
QIDI Vida uses high-tech HUD (Head-Up Display) which is similar to the technology used for aircrafts and premium cars and introduces it to the sports industry. Users can activate the HUD function at any time using voice control, enabling them to focus on the route ahead whilst simultaneously having access to information such as navigation, speed, heart rate, power and cadence, among other metrics. Another great function of the QIDI Vida is that users can also enjoy audiovisual entertainment through the optically perceived 100-inch AR HUD screen, when having some down time.
As cyclists and hikers often travel in groups, QIDI Vida supports eSIM and team functionality, allowing real-time voice communication without releasing handlebars, and users can monitor their groups’ real-time locations. The glasses also have comprehensive sensing and monitoring capabilities including temperature, humidity, UV, air pressure, geomagnetism and acceleration. In addition to obtaining environmental and health information, it also features health warnings such as altitude sickness symptoms and high heart rate, as well as fall and collision detection functions. And, in the event of danger, it can send distress signals to teammates.
Perks:
QIDI Vida has a global voice recognition and interaction feature that allows you to control all functions within the device by voice. To better provide users with an immersive sports experience, QIDI Vida’s intelligent system will have the capability to instantly gather personalised sports data, enabling it to deliver timely voice alerts and broadcasts, including the duration of exercise, distance, the environment and the weather – all tailored to the user’s preferences.
QIDI Vida enables voice-controlled photos and video recordings, allowing users to capture moments whilst cycling or hiking without the need to stop. QIDI Vida supports connections with common cycling smart hardware such as Garmin, Wahoo, Apple, and Samsung, supports GPX route files, and is compatible with professional sports apps such as Strava, Keep, Zwift, Apple Health, and All Trails.
QIDI Vida stands out for its lightweight and comfortable design with a dual lens for a full-colour data display, unlike competing AR glasses that typically have a single lens and limited colour. This innovation significantly enhances and augments the user’s sports and reality experience.
QIDI Vida will launch on the Kickstarter platform: https://www.kickstarter.com/projects/109560964/qidi-vida-smart-ar-glasses-for-sports
HIGH RES IMAGE: https://we.tl/t-epx2syiuaRWATCH VIDEO: https://www.youtube.com/watch?v=2v_Pli2pAM8&t=164s
Photo – https://mma.prnewswire.com/media/2392090/2.jpgPhoto – https://mma.prnewswire.com/media/2392092/3.jpgPhoto – https://mma.prnewswire.com/media/2392093/4.jpgPhoto – https://mma.prnewswire.com/media/2392089/1_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/free-your-hands-qidi-vida-smart-ar-glasses-lead-the-way-in-new-sports-experience-302122189.html
Artificial Intelligence
Risk Analytics Market worth $180.9 billion by 2029 – Exclusive Report by MarketsandMarkets™
CHICAGO, April 19, 2024 /PRNewswire/ — The growing use of real-time monitoring and advanced analytics, integration with cutting-edge technologies like blockchain and IoT, and an emphasis on cybersecurity, cross-industry applications, and regulatory compliance are the key factors that will shape the risk analytics market in the future. The market’s development will also be influenced by collaborative risk management, improved user experience, and an increasing focus on ESG factors and risk culture.
The Risk Analytics Market is estimated to grow from USD 59.7 billion in 2024 to USD 180.9 billion in 2029, at a CAGR of 24.8% during the forecast period, according to a new report by MarketsandMarkets™. Several trends fuel the global spread of Risk Analytics. Increasingly Increasing Data Complexity, Rising Cybersecurity Threats and Rising Adoption of Cloud-Based Solutions A growing talent pool of data scientists and engineers is building the necessary tools and infrastructure. Governments are recognizing the potential of risk analytics for economic growth and are investing in research and development. These trends make DI more accessible and valuable, leading to its global adoption.
Browse in-depth TOC on “Risk Analytics Market”260 – Tables 60 – Figures350 – Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210662258
Scope of the Report
Report Metrics
Details
Market size available for years
2019–2023
Base year considered
2023
Forecast period
2024–2029
Forecast units
USD Billion
Segments Covered
Offering,Risk Type, Risk stages, Vertical, and Region.
Geographies covered
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America
Companies covered
IBM (US), SAS Institute (US), Oracle (US), FIS(US), Moody’s Analytics (US), ProcessUnity(US), ServiceNow (US), Marsh (US), Aon (UK), MetricStream (US), Resolver (Canada), SAP (Germany), Milliman(US), LogicManager(US), Provenir(US), SAI360(US), Deloitte(UK), OneTrust(US), Diligent(US), Alteryx(US), CRISIL(India), Archer(US), ZestyAI(US), Fusion Risk Management(US), RiskVille(Ireland), SPIN Analytics(UK), Kyvos Insights(US), Imperva(US), Cirium(UK), Quantexa(UK), ClickUp(US), Sprinto(US), Ventiv(US), Adenza(US), Centrl.AI(Canada), SafetyCulture(Australia), Quantifi(US), CubeLogic(UK), Onspring(US), Riskoptics(US)
By offering the services segment to account for higher CAGR during the forecast period
In the Risk Analytics Market, the highest CAGR of services is fueled by Increasing Complexity of Risks, AI and machine learning advancements, big data analytics integration, business process optimization, cloud-based solutions adoption, data-driven culture, and diverse industry adoption. These trends reflect a global shift towards leveraging data for competitive advantage, driving a continuous need for sophisticated risk analytics services across sectors. As businesses prioritize agility, the growth of services in the Risk Analytics Market is driven by the need for effective risk management strategies in an increasingly complex and uncertain business environment.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=210662258
By Type, GRC software is expected to hold the largest market size for the year 2024
GRC software typically offers comprehensive solutions that cover a wide range of risk management needs, including compliance management, policy management, audit management, and risk assessment. They also provide organizations with enhanced visibility into their risk landscape. Through features such as risk assessment, risk monitoring, and reporting, organizations can identify and prioritize risks more effectively, enabling proactive risk management strategies. GRC software streamlines risk management processes through automation, reducing manual effort and increasing efficiency. Tasks such as risk assessments, control testing, and incident management can be automated, freeing up resources to focus on strategic risk mitigation efforts. the combination of comprehensive functionality, regulatory compliance support, efficiency gains, scalability, integration capabilities, and culture enhancement makes GRC software a preferred choice for many organizations seeking to manage risk effectively.
By Vertical, Healthcare & Life Sciences is projected to grow at the highest CAGR during the forecast period
The Healthcare and Lifesciences is experiencing a surge in the adoption of risk analytics due to a confluence of factors. Healthcare providers and life sciences companies wants to ensure the safety and well-being of patients. Risk analytics helps in identifying potential risks to patient safety, such as medication errors, adverse events, and medical device failures. The healthcare and life sciences industries are heavily regulated, with strict guidelines for patient care, data privacy, drug development, and clinical trials. Risk analytics helps organizations ensure compliance with these regulations by identifying and mitigating risks of non-compliance. Healthcare organizations and life sciences companies also face financial risks associated with fraud, billing errors, revenue cycle management, and reimbursement challenges. Risk analytics helps in detecting anomalies and optimizing financial processes to mitigate these risks.
Asia Pacific is expected to grow at the highest CAGR during the forecast period
The Asia-Pacific (APAC) region is experiencing rapid growth in the Risk Analytics Market, boasting the highest Compound Annual Growth Rate (CAGR). This surge is primarily attributed to rising demand for data-driven decision-making solutions, expanding digital transformation initiatives across industries.. Moreover, the region’s favorable regulatory environment, growing investments in big data analytics, and the integration of advanced technologies like the Internet of Things (IoT) further propel APAC’s dominance in Risk Analytics Market growth.
Top Key Companies in Risk Analytics Market:
The major risk analytics software and service providers include IBM (US), SAS Institute (US), Oracle (US), FIS(US), Moody’s Analytics (US), ProcessUnity(US), ServiceNow (US), Marsh (US), Aon (UK), MetricStream (US), Resolver (Canada), SAP (Germany), Milliman(US), LogicManager(US), Provenir(US), SAI360(US), Deloitte(UK), OneTrust(US), Diligent(US), Alteryx(US), CRISIL(India), Archer(US), ZestyAI(US), Fusion Risk Management(US), RiskVille(Ireland), SPIN Analytics(UK), Kyvos Insights(US), Imperva(US), Cirium(UK), Quantexa(UK), ClickUp(US), Sprinto(US), Ventiv(US), Adenza(US), Centrl.AI(Canada), SafetyCulture(Australia), Quantifi(US), CubeLogic(UK), Onspring(US), Riskoptics(US). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the Risk Analytics Market.
Recent Developments:
In March 2024, Orcale announced Oracle Risk Management Cloud in Release 24B. It offers comprehensive solution designed to help organizations identify, assess, and mitigate risks across their business operations. It offers advanced analytics, automation, and collaboration tools to streamline risk management.In March 2024, FIS Global announces card fraud detection capabilities leveraging artificial intelligence (AI) with aim to bolster FIS’s ability to identify and prevent fraudulent transactions, providing greater security for cardholders and financial institutions alike.In March 2024, Aon acquired an AI-powered platform to assist fleet and mobility clients in making data-driven decisions, enhancing operational efficiency and risk management. The platform utilizes artificial intelligence to analyze data and provide insights, enabling clients to optimize their fleet operations and improve decision-making processes.In March 2024, Crisp joined Resolver, with the aim to enhance Resolver’s risk intelligence capabilities by integrating Crisp’s expertise and technology into its platform, offering clients improved risk assessment and mitigation tools.In February 2024, SAS partnered with Carahsoft to bring analytics, AI, and data management solutions to the public sector. The aim is to leverage SAS’s expertise in advanced analytics and Carahsoft’s extensive government market reach to offer tailored solutions that enable public sector organizations to harness the power of data for informed decision-making and improved outcomes.Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=210662258
Risk Analytics Market Advantages:
By offering insights into potential risks, opportunities, and trends, risk analytics helps organisations make data-driven decisions that improve strategic planning and resource allocation.In order to improve risk management procedures and lessen exposure to possible threats, risk analytics solutions assist businesses in identifying, evaluating, and mitigating risks across a range of business activities, including finance, operations, and compliance.Through real-time monitoring and anomaly detection made possible by risk analytics, organisations may proactively address shifting market situations, legal requirements, and cybersecurity threats.Risk analytics solutions assist organisations lower operating costs, increase productivity, and streamline compliance activities, which results in cost savings and resource optimisation. They do this by streamlining risk management procedures and automating routine work.Accurate risk assessments, audit trails, and reporting capabilities are just a few of the ways that risk analytics solutions help organisations comply with regulations and stay out of trouble.Organisations can enhance their resilience and competitiveness by anticipating and mitigating potential hazards before they materialise through the use of predictive modelling and advanced analytics approaches in risk analytics.Report Objectives
To define, describe, and predict the Risk Analytics Market by offering, risk type, risk stages, vertical, and regionTo provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the market growthTo analyze the opportunities in the market and provide details of the competitive landscape for stakeholders and market leadersTo forecast the market size of segments with respect to five main regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin AmericaTo profile the key players and comprehensively analyze their market rankings and core competenciesTo analyze the competitive developments, such as partnerships, product launches, and mergers & acquisitions, in the Risk Analytics MarketBrowse Adjacent Markets: Analytics Market Research Reports & Consulting
Related Reports:
Customer Data Platform Market – Global Forecast to 2028
Speech Analytics Market- Global Forecast to 2029
Text to Video AI Market – Global Forecast to 2027
Contact Center Analytics Market- Global Forecast to 2027
Procurement Analytics Market- Global Forecast to 2026
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Insight: https://www.marketsandmarkets.com/ResearchInsight/risk-analytics-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/risk-analytics.asp
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/risk-analytics-market-worth-180-9-billion-by-2029—exclusive-report-by-marketsandmarkets-302121085.html
-
Artificial Intelligence6 days agoSilent Eight secures AIA as its latest client
-
Artificial Intelligence3 days agoHuawei Introduces AI Technologies to Accelerate Network Transformation Towards All Intelligence in the Net5.5G Era
-
Artificial Intelligence5 days agoGlobal Networking Innovator Huawei Leads the New Era of Campus Network Technology
-
Artificial Intelligence5 days agoBroadcom Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Delivering Reliable and Flexible Hybrid Cloud Management Solutions
-
Artificial Intelligence5 days agoGFT teams up with Google Cloud to launch ‘GenAI Intelligent Assistant’
-
Artificial Intelligence4 days agovLex Launches Vastly Expanded Vincent Legal GenAI Toolset, and AI-Focused Co-Development Lab
-
Artificial Intelligence5 days agoELEGOO Adds Two New Innovations To Its Saturn Series, Ushering In A New Era Of Precision 3D Printing
-
Artificial Intelligence4 days agoGEP NAMED ‘LEADER’ IN MULTIPLE GLOBAL PROCUREMENT SERVICES REPORTS BY TOP ANALYST FOR FOURTH YEAR IN A ROW
